Axonics Balance Sheet Health
Financial Health criteria checks 6/6
Axonics has a total shareholder equity of $643.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $747.3M and $104.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$343.41m |
| Equity | US$643.32m |
| Total liabilities | US$104.02m |
| Total assets | US$747.34m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AXNX *'s short term assets ($512.1M) exceed its short term liabilities ($57.2M).
Long Term Liabilities: AXNX *'s short term assets ($512.1M) exceed its long term liabilities ($46.8M).
Debt to Equity History and Analysis
Debt Level: AXNX * is debt free.
Reducing Debt: AXNX * has no debt compared to 5 years ago when its debt to equity ratio was 17.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AXNX * has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AXNX * is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 24.6% per year.